EP0704530A2 - A kanamycin resistance gene derived from microorganisms of the genus rhodococcus - Google Patents
A kanamycin resistance gene derived from microorganisms of the genus rhodococcus Download PDFInfo
- Publication number
- EP0704530A2 EP0704530A2 EP95112298A EP95112298A EP0704530A2 EP 0704530 A2 EP0704530 A2 EP 0704530A2 EP 95112298 A EP95112298 A EP 95112298A EP 95112298 A EP95112298 A EP 95112298A EP 0704530 A2 EP0704530 A2 EP 0704530A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- sequence
- genus rhodococcus
- kanamycin resistance
- gene
- microorganisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
Definitions
- the present invention relates to a gene derived from microorganisms of the genus Rhodococcus and conferring kanamycin resistance on bacteria, as well as a plasmid vector containing the same.
- Microorganisms belonging to the genus Rhodococcus are known as bacterial catalysts that hydrate or hydrolyze nitriles to the corresponding amides or acids (Japanese Patent Publication No. 4873/92 and Japanese Laid-Open Patent Publication Nos. 91189/87, 470/90 and 84198/90), and in particular, microorganisms belonging to the species Rhodococcus rhodochrous possess nitrile-hydrating activity of extremely high performance (Japanese Laid-Open Patent Publication No. 470/90).
- one of the present inventors found cryptic plasmids in a certain strain of the species Rhodococcus rhodochrous and constructed hybrid plasmid vectors to develop a host-vector system of the genus Rhodococcus (Japanese Laid-Open Patent Publication Nos. 148685/92, 64589/93 and 68566/93).
- the present inventors With the aim of establishing a self-cloning system of the genus Rhodococcus, the present inventors extensively studied drug resistance genes derived from microorganisms of the genus Rhodococcus, in particular the species Rhodococcus rhodochrous, so that they found the kanamycin resistance gene of the present invention.
- the present invention relates to a gene derived from microorganisms of the genus Rhodococcus and conferring kanamycin resistance on hosts, wherein said gene codes for the amino acid sequence of Sequence No. 1 or a polypeptide containing a partial sequence thereof.
- the present invention furthermore relates to a gene conferring kanamycin resistance on a host comprising the DNA sequence of Sequence No. 2 or a DNA sequence which
- hybridization refers to conventional hybridization conditions, preferably to stringent hybridization conditions.
- FIG. 1 shows a restriction enzyme map of plasmid pKM001.
- FIG. 2 shows the construction of plasmid pKM002, pKM003 and pKM004.
- FIG. 3 shows a restriction enzyme map of plasmid pKM011.
- kanamycin mutant KM-02 deposited as FERM BP-5137 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan
- FERM BP-5137 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan
- Rhodococcus rhodochrous ATCC 12674 was obtained by spontaneous mutation of Rhodococcus rhodochrous ATCC 12674.
- plasmid vectors including but not limited to E . coli vectors such as pTrc99A, pUC18, etc. and phage vectors such as ⁇ gt11 etc.
- the host microorganisms include but are not limited to E . coli JM109, E . coli JM105, and Rhodococcus rhodochrous ATCC 12674.
- Plasmids that provide plasmid vectors constructed of the kanamycin resistance gene of the invention with a region capable of replicating in microorganisms of the genus Rhodococcus include, but are not limited to, plasmids pRC001, pRC002, pRC003 and pRC004.
- the plasmids pRC001, pRC002, pRC003 and pRC004 are derived from Rhodococcus rhodochrous ATCC 4276, ATCC 14349, ATCC 14348 and IFO 3338, respectively, and these plasmids are described in the aforementioned Japanese Laid-Open Patent Publication Nos. 148685/92, 64589/93 and 68566/93, respectively.
- the present kanamycin resistance gene derived from microorganisms of the genus Rhodococcus is useful to construct vectors for microorganisms of the genus Rhodococcus , particularly vectors for self-cloning of Rhodococcus rhodochrous .
- the KM-02 strain was cultured under shaking at 30 °C in 100 ml MY medium (0.5 % polypeptone, 0.3 % Bacto-yeast extract, 0.3 % Bacto-malt extract) and genomic DNA was prepared from the bacteria according to the method by Saito and Miura (Biochim. Biophys. Acta 72 , 619 (1963)). A part of the resulting DNA was partially digested with restriction enzyme Sau 3AI and then inserted into a Bam HI site of E. coli vector pTrc99A to give a recombinant DNA library.
- the recombinant library prepared in step (1) was used to transform E . coli JM109 by the calcium chloride method, and transformants with resistance to kanamycin were selected in the following manner.
- the transformants obtained above were plated onto LB agar medium (1 % Bacto-trypton, 0.5 % Bacto-yeast extract, 0.5 96 NaCl, 1.5 % agar) containing 40 ⁇ g/ml kanamycin hydrochloride and 1 mM IPTG (isopropyl- ⁇ -thiogalactoside) and incubated overnight at 37 °C. The colonies occurring thereon were removed and applied onto the same agar medium, and their growth was confirmed.
- LB agar medium 1 % Bacto-trypton, 0.5 % Bacto-yeast extract, 0.5 96 NaCl, 1.5 % agar
- IPTG isopropyl- ⁇ -thiogalactoside
- a plasmid DNA was prepared from the thus obtained transformant according to the method by Birnboim and Doly (Nucleic Acid Res. 7, 1513-1523 (1979)) and designated pKM001.
- This plasmid was reintroduced into E . coli , and the resultant transformant with kanamycin resistance was designated JM109/pKM001 and deposited as FERM BP-5138 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology. IPTG was required for expression of Kanamycin resistance of E. coli JM109/pKM001.
- a restriction enzyme map of plasmid pKM001 obtained in step (2) was prepared (FIG. 1). Thereafter, this plasmid pKM001 was used for preparing plasmids of a smaller DNA fragment.
- the target gene-containing region was identified by the presence or absence of the kanamycin resistance of transformants prepared in the same manner as in step (2). During this process, plasmid pKM002 (FIG. 2) was constructed.
- the nucleotide sequence of the kanamycin resistance gene in plasmid pKM002 was determined by Fluorescence Sequencer ALF II produced by Pharmacia (Sequence No. 3).
- Hybrid E . Coli - Rhodococcus
- Plasmid Vector Carrying the Kanamycin Resistance Gene Derived from Rhodococcus Rhodochrous
- a hybrid plasmid vector pK4 previously constructed by one of the present inventors by ligating Rhodococcus -derived plasmid pRC004 with E . coli vector pHSG299 and deposited as FERM BP-3731 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology (Japanese Laid-Open Patent Publication Nos. 64589/93 and 68566/93), was used for preparing a 3.1 kb Hind III fragment containing the whole of pRC004 and a part of pHSG299, and the resulting fragment was ligated with the plasmid pKM002.
- pKM003 and pKM004 Two plasmids carrying the insert in the opposite direction were obtained and designated pKM003 and pKM004, respectively (FIG. 2). These plasmids replicate in both the genus Rhodococcus and E . coli .
- Rhodococcus rhodochrous ATCC 12674 was transformed with these plasmids by electroporation, whereby a transformant capable of growing in MY medium containing 75 ⁇ g/ml kanamycin was obtained.
- the plasmids obtained from the transformant were the same plasmids as those introduced. Where microorganisms of the genus Rhodococcus were used as the host, the presence of IPTG was not required for expression of kanamycin resistance.
- the hybrid plasmid vector pKM004 was cleaved with restriction enzyme Kpn I to give a 4.3 kb Kpn I fragment which was then self-ligated and introduced into Rhodococcus rhodochrous ATCC 12674 by electroporation.
- the resulting transformant showed the same degree of kanamycin resistance as did the transformant of Example 2. From this transformant, a plasmid was obtained and designated pKM011 (FIG. 3).
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
- The present invention relates to a gene derived from microorganisms of the genus Rhodococcus and conferring kanamycin resistance on bacteria, as well as a plasmid vector containing the same.
- Microorganisms belonging to the genus Rhodococcus are known as bacterial catalysts that hydrate or hydrolyze nitriles to the corresponding amides or acids (Japanese Patent Publication No. 4873/92 and Japanese Laid-Open Patent Publication Nos. 91189/87, 470/90 and 84198/90), and in particular, microorganisms belonging to the species Rhodococcus rhodochrous possess nitrile-hydrating activity of extremely high performance (Japanese Laid-Open Patent Publication No. 470/90).
- Under such circumstances, one of the present inventors found cryptic plasmids in a certain strain of the species Rhodococcus rhodochrous and constructed hybrid plasmid vectors to develop a host-vector system of the genus Rhodococcus (Japanese Laid-Open Patent Publication Nos. 148685/92, 64589/93 and 68566/93).
- For construction of a self-cloning system of higher safety, it is also necessary to develop marker genes derived from microorganisms of the genus Rhodococcus. However, only arsenious acid and cadmium resistance genes derived from microorganisms of the species Rhodococcus rhodochrous are known as such drug resistance genes (Plasmid 23, 242-247 (1990)).
- With the aim of establishing a self-cloning system of the genus Rhodococcus, the present inventors extensively studied drug resistance genes derived from microorganisms of the genus Rhodococcus, in particular the species Rhodococcus rhodochrous, so that they found the kanamycin resistance gene of the present invention.
- That is, the present invention relates to a gene derived from microorganisms of the genus Rhodococcus and conferring kanamycin resistance on hosts, wherein said gene codes for the amino acid sequence of Sequence No. 1 or a polypeptide containing a partial sequence thereof.
- The present invention furthermore relates to a gene conferring kanamycin resistance on a host comprising the DNA sequence of Sequence No. 2 or a DNA sequence which
- (a) differs from said DNA sequence due to the degeneracy of the genetic code;
- (b) hybridizes with said DNA sequence or the DNA sequence of (a); or
- (c) represents a fragment, allelic or other variation of the above DNA sequence, whether said variation results in changes in the polypeptide sequence or not.
- In this context, the term "hybridization" refers to conventional hybridization conditions, preferably to stringent hybridization conditions.
- FIG. 1 shows a restriction enzyme map of plasmid pKM001.
- FIG. 2 shows the construction of plasmid pKM002, pKM003 and pKM004.
- FIG. 3 shows a restriction enzyme map of plasmid pKM011.
- As the DNA donor in the present invention, mention may be made of kanamycin mutant KM-02 (deposited as FERM BP-5137 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan) which was obtained by spontaneous mutation of Rhodococcus rhodochrous ATCC 12674.
- As the vectors used in cloning in the present invention, mention may be made of plasmid vectors including but not limited to E. coli vectors such as pTrc99A, pUC18, etc. and phage vectors such as λ gt11 etc. The host microorganisms include but are not limited to E. coli JM109, E. coli JM105, and Rhodococcus rhodochrous ATCC 12674.
- Plasmids that provide plasmid vectors constructed of the kanamycin resistance gene of the invention with a region capable of replicating in microorganisms of the genus Rhodococcus include, but are not limited to, plasmids pRC001, pRC002, pRC003 and pRC004. The plasmids pRC001, pRC002, pRC003 and pRC004 are derived from Rhodococcus rhodochrous ATCC 4276, ATCC 14349, ATCC 14348 and IFO 3338, respectively, and these plasmids are described in the aforementioned Japanese Laid-Open Patent Publication Nos. 148685/92, 64589/93 and 68566/93, respectively.
- The present kanamycin resistance gene derived from microorganisms of the genus Rhodococcus is useful to construct vectors for microorganisms of the genus Rhodococcus, particularly vectors for self-cloning of Rhodococcus rhodochrous.
- The present invention is described in more detail with reference to the following examples, which however are not intended to limit the scope of the present invention.
- The KM-02 strain was cultured under shaking at 30 °C in 100 ml MY medium (0.5 % polypeptone, 0.3 % Bacto-yeast extract, 0.3 % Bacto-malt extract) and genomic DNA was prepared from the bacteria according to the method by Saito and Miura (Biochim. Biophys. Acta 72, 619 (1963)). A part of the resulting DNA was partially digested with restriction enzyme Sau3AI and then inserted into a BamHI site of E. coli vector pTrc99A to give a recombinant DNA library.
- The recombinant library prepared in step (1) was used to transform E. coli JM109 by the calcium chloride method, and transformants with resistance to kanamycin were selected in the following manner.
- The transformants obtained above were plated onto LB agar medium (1 % Bacto-trypton, 0.5 % Bacto-yeast extract, 0.5 96 NaCl, 1.5 % agar) containing 40 µ g/ml kanamycin hydrochloride and 1 mM IPTG (isopropyl-β -thiogalactoside) and incubated overnight at 37 °C. The colonies occurring thereon were removed and applied onto the same agar medium, and their growth was confirmed.
- A plasmid DNA was prepared from the thus obtained transformant according to the method by Birnboim and Doly (Nucleic Acid Res. 7, 1513-1523 (1979)) and designated pKM001. This plasmid was reintroduced into E. coli, and the resultant transformant with kanamycin resistance was designated JM109/pKM001 and deposited as FERM BP-5138 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology. IPTG was required for expression of Kanamycin resistance of E. coli JM109/pKM001.
- A restriction enzyme map of plasmid pKM001 obtained in step (2) was prepared (FIG. 1). Thereafter, this plasmid pKM001 was used for preparing plasmids of a smaller DNA fragment. The target gene-containing region was identified by the presence or absence of the kanamycin resistance of transformants prepared in the same manner as in step (2). During this process, plasmid pKM002 (FIG. 2) was constructed.
- The nucleotide sequence of the kanamycin resistance gene in plasmid pKM002 was determined by Fluorescence Sequencer ALF II produced by Pharmacia (Sequence No. 3).
- A hybrid plasmid vector pK4, previously constructed by one of the present inventors by ligating Rhodococcus-derived plasmid pRC004 with E. coli vector pHSG299 and deposited as FERM BP-3731 with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology (Japanese Laid-Open Patent Publication Nos. 64589/93 and 68566/93), was used for preparing a 3.1 kb HindIII fragment containing the whole of pRC004 and a part of pHSG299, and the resulting fragment was ligated with the plasmid pKM002.
- As a result, two plasmids carrying the insert in the opposite direction were obtained and designated pKM003 and pKM004, respectively (FIG. 2). These plasmids replicate in both the genus Rhodococcus and E. coli. Rhodococcus rhodochrous ATCC 12674 was transformed with these plasmids by electroporation, whereby a transformant capable of growing in MY medium containing 75µ g/ml kanamycin was obtained. The plasmids obtained from the transformant were the same plasmids as those introduced. Where microorganisms of the genus Rhodococcus were used as the host, the presence of IPTG was not required for expression of kanamycin resistance.
- The hybrid plasmid vector pKM004 was cleaved with restriction enzyme KpnI to give a 4.3 kb KpnI fragment which was then self-ligated and introduced into Rhodococcus rhodochrous ATCC 12674 by electroporation. The resulting transformant showed the same degree of kanamycin resistance as did the transformant of Example 2. From this transformant, a plasmid was obtained and designated pKM011 (FIG. 3).
Claims (9)
- A gene derived from a microorganism of the genus Rhodococcus and conferring kanamycin resistance on a host, said gene coding for the amino acid sequence of Sequence No. 1 or a polypeptide containing a partial sequence thereof.
- The gene according to claim 1, comprising the DNA sequence of Sequence No. 2 or a partial sequence thereof.
- A gene conferring kanamycin resistance on a host and comprising a DNA sequence which(a) differs from the DNA sequence of claim 2 in the codon sequence due to the degeneracy of the genetic code;(b) hybridizes with the DNA sequence of claim 2 or section (a), above; or(c) represents a fragment, allelic or other variation of the DNA sequence of claim 2, whether said variation results in changes in the polypeptide sequence or not.
- The gene according to any one of claims 1 to 3, wherein the host microorganism is a microorganism of the genus Rhodococcus or Escherichia coli.
- A plasmid vector comprising a gene according to any one of claims 1 to 4 and a DNA region capable of replicating in a microorganism of the genus Rhodococcus.
- The plasmid vector according to claim 5, wherein the DNA region capable of replicating in a microorganism of the genus Rhodococcus is derived from a plasmid selected from pRC001, pRC002, pRC003 or pRC004.
- A host cell transformed with the plasmid of claim 5 or 6.
- The host cell of claim 7, which is a cell of a microorganism of the genus Rhodococcus or Escherichia coli.
- Use of the gene of any one of claims 1 to 4 as a marker for the construction of a self-cloning system.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20158294 | 1994-08-04 | ||
JP20158294A JP3235934B2 (en) | 1994-08-04 | 1994-08-04 | Kanamycin resistance gene from Rhodococcus bacteria |
JP201582/94 | 1994-08-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0704530A2 true EP0704530A2 (en) | 1996-04-03 |
EP0704530A3 EP0704530A3 (en) | 1997-12-29 |
EP0704530B1 EP0704530B1 (en) | 2003-10-29 |
Family
ID=16443451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95112298A Expired - Lifetime EP0704530B1 (en) | 1994-08-04 | 1995-08-04 | A kanamycin resistance gene derived from microorganisms of the genus rhodococcus |
Country Status (7)
Country | Link |
---|---|
US (1) | US5776771A (en) |
EP (1) | EP0704530B1 (en) |
JP (1) | JP3235934B2 (en) |
KR (1) | KR100343424B1 (en) |
CN (1) | CN1080308C (en) |
DE (1) | DE69532024T2 (en) |
TW (1) | TW338069B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949362B2 (en) | 2000-12-12 | 2005-09-27 | E. I. Du Pont De Nemours And Company | Rhodococcus cloning and expression vectors |
US8871503B2 (en) | 2006-03-28 | 2014-10-28 | Isis Innovation Limited | Construct |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586661B1 (en) | 1997-06-12 | 2003-07-01 | North Carolina State University | Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid |
DE19803219A1 (en) * | 1998-01-28 | 1999-08-12 | Fraunhofer Ges Forschung | Method and device for determining the surface friction coefficient of bodies |
DE19926216A1 (en) * | 1999-06-09 | 2001-02-22 | Metallgesellschaft Ag | Process for producing barium sulfate, barium sulfate and use of barium sulfate |
US6911541B2 (en) * | 2000-08-30 | 2005-06-28 | North Carolina State University | Promoter fragment that is recognized by the product of the tobacco Nic gene |
DE60128149D1 (en) * | 2000-11-07 | 2007-06-06 | Univ North Carolina State | Putrescin-n-methyltransferasepromotor |
US20060157072A1 (en) * | 2001-06-08 | 2006-07-20 | Anthony Albino | Method of reducing the harmful effects of orally or transdermally delivered nicotine |
JP2004530430A (en) * | 2001-06-08 | 2004-10-07 | ベクター、タバコ、リミテッド | Changes in nicotine and nitrosamine concentrations in tobacco |
US20040115661A1 (en) * | 2001-12-12 | 2004-06-17 | Bramucci Michael G. | Rhodococcus cloning and expression vectors |
WO2003086076A1 (en) * | 2002-04-09 | 2003-10-23 | Vector Tobacco Ltd. | Tobacco having reduced nicotine and nitrosamines |
JP4495429B2 (en) * | 2003-09-24 | 2010-07-07 | 三菱レイヨン株式会社 | Transformation method of Rhodococcus bacteria |
JP4493011B2 (en) * | 2004-06-11 | 2010-06-30 | 三菱レイヨン株式会社 | Trimethoprim-resistant dihydrofolate reductase and its gene from Rhodococcus spp. |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6291189A (en) | 1985-06-04 | 1987-04-25 | Asahi Chem Ind Co Ltd | Microbiological production of amide |
JPH02470A (en) | 1987-09-18 | 1990-01-05 | Hideaki Yamada | Biological production of amide |
JPH0284198A (en) | 1988-06-27 | 1990-03-26 | Asahi Chem Ind Co Ltd | Production of optically active alpha-substituted organic acid and organism and enzyme to be used therefor |
JPH044873A (en) | 1990-04-24 | 1992-01-09 | Shiseido Co Ltd | Production of peptide c-terminal amidating enzyme |
JPH04148685A (en) | 1990-10-11 | 1992-05-21 | Nitto Chem Ind Co Ltd | Cyclic plasmid |
JPH0564589A (en) | 1991-03-04 | 1993-03-19 | Teruhiko Beppu | Composite plasmid vector and transformed microorganism |
JPH0568566A (en) | 1991-03-04 | 1993-03-23 | Teruhiko Beppu | Recombinant plasmid having nitrile decomposing enzymic gene, transformed microorganism and production of amide and acid by the same transformed microorganism |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920054A (en) * | 1986-07-25 | 1990-04-24 | Allelix, Inc. | Shuttle vectors from rhodococcus equi |
US5246857A (en) * | 1990-10-11 | 1993-09-21 | Nitto Chemical Industry Co., Ltd. | Circular plasmids derived from the genus rhodococcus |
DE69231939T2 (en) * | 1991-03-04 | 2002-04-04 | Mitsubishi Rayon Co | Hybrid plasmid vectors containing genes coding for nitrile-degrading enzymes and methods for producing amides and acids |
-
1994
- 1994-08-04 JP JP20158294A patent/JP3235934B2/en not_active Expired - Lifetime
-
1995
- 1995-08-03 US US08/510,878 patent/US5776771A/en not_active Expired - Lifetime
- 1995-08-04 KR KR1019950024035A patent/KR100343424B1/en not_active IP Right Cessation
- 1995-08-04 DE DE69532024T patent/DE69532024T2/en not_active Expired - Lifetime
- 1995-08-04 CN CN95115824A patent/CN1080308C/en not_active Expired - Lifetime
- 1995-08-04 EP EP95112298A patent/EP0704530B1/en not_active Expired - Lifetime
- 1995-09-18 TW TW084109776A patent/TW338069B/en not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6291189A (en) | 1985-06-04 | 1987-04-25 | Asahi Chem Ind Co Ltd | Microbiological production of amide |
JPH02470A (en) | 1987-09-18 | 1990-01-05 | Hideaki Yamada | Biological production of amide |
JPH0284198A (en) | 1988-06-27 | 1990-03-26 | Asahi Chem Ind Co Ltd | Production of optically active alpha-substituted organic acid and organism and enzyme to be used therefor |
JPH044873A (en) | 1990-04-24 | 1992-01-09 | Shiseido Co Ltd | Production of peptide c-terminal amidating enzyme |
JPH04148685A (en) | 1990-10-11 | 1992-05-21 | Nitto Chem Ind Co Ltd | Cyclic plasmid |
JPH0564589A (en) | 1991-03-04 | 1993-03-19 | Teruhiko Beppu | Composite plasmid vector and transformed microorganism |
JPH0568566A (en) | 1991-03-04 | 1993-03-23 | Teruhiko Beppu | Recombinant plasmid having nitrile decomposing enzymic gene, transformed microorganism and production of amide and acid by the same transformed microorganism |
Non-Patent Citations (2)
Title |
---|
NUCLEIC ACID RES., vol. 7, 1979, pages 1513 - 1523 |
PLASMID, vol. 23, 1990, pages 242 - 247 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949362B2 (en) | 2000-12-12 | 2005-09-27 | E. I. Du Pont De Nemours And Company | Rhodococcus cloning and expression vectors |
US7416859B2 (en) | 2000-12-12 | 2008-08-26 | E.I. Du Pont De Nemours And Company | Rhodococcus cloning and expression vectors |
US8871503B2 (en) | 2006-03-28 | 2014-10-28 | Isis Innovation Limited | Construct |
US11214815B2 (en) | 2006-03-28 | 2022-01-04 | Ip2Ipo Innovations Limited | Nucleic acid Construct |
Also Published As
Publication number | Publication date |
---|---|
EP0704530B1 (en) | 2003-10-29 |
CN1133342A (en) | 1996-10-16 |
EP0704530A3 (en) | 1997-12-29 |
DE69532024T2 (en) | 2004-06-24 |
KR100343424B1 (en) | 2002-11-14 |
TW338069B (en) | 1998-08-11 |
JPH0838184A (en) | 1996-02-13 |
US5776771A (en) | 1998-07-07 |
KR960007778A (en) | 1996-03-22 |
DE69532024D1 (en) | 2003-12-04 |
CN1080308C (en) | 2002-03-06 |
JP3235934B2 (en) | 2001-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0704530B1 (en) | A kanamycin resistance gene derived from microorganisms of the genus rhodococcus | |
US5635391A (en) | Isolated DNA encoding a nitrilase polypeptide, hosts containing, and expression thereof optionally assisted by a E. coli GroE chaperone polypeptide | |
DiRUSSO | Primary sequence of the Escherichia coli fadBA operon, encoding the fatty acid-oxidizing multienzyme complex, indicates a high degree of homology to eucaryotic enzymes | |
US5731176A (en) | DNA fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant | |
Charlier et al. | carP, Involved in Pyrimidine Regulation of theEscherichia coliCarbamoylphosphate Synthetase Operon Encodes a Sequence-specific DNA-binding Protein Identical to XerB and PepA, also Required for Resolution of ColEl Multimers | |
CA2103616A1 (en) | Polypeptides possessing a nitrilase activity, dna sequence coding for said polypeptides, expression cassettes and host microorganisms enabling them to be obtained, and method of converting nitriles to carboxylates by means of said polypeptides | |
US5700661A (en) | Gene expression regulatory DNA | |
US5888785A (en) | Method for using hydratase or a hydratase-amidase fusion for stereospecifically bioconverting certain racemic nitriles to the corresponding enatiomeric R--or S-amide or s-carboxylic acid | |
Sykes et al. | Molecular cloning of genes encoding branched-chain keto acid dehydrogenase of Pseudomonas putida | |
EP1019487A1 (en) | Expression control sequences | |
EP0719862B1 (en) | A regulatory factor for expression of nitrilase gene and a gene thereof | |
EP0780471B1 (en) | Novel nitrilase gene | |
US5622840A (en) | Method for controlling gene expression | |
Sun et al. | Cloning and nucleotide sequence of the Bacillus subtilis ansR gene, which encodes a repressor of the ans operon coding for L-asparaginase and L-aspartase | |
Wiese et al. | Organization of genes responsible for the stereospecific conversion of hydantoins to α-amino acids in Arthrobacter aurescens DSM 3747 | |
JP2754975B2 (en) | Farnesyl diphosphate synthase and DNA sequence encoding the same | |
Murai et al. | A novel insertion sequence (IS)-like element of the thermophilic bacterium PS3 promotes expression of the alanine carrier protein-encoding gene | |
Azza et al. | Cloning of the wide spectrum amidase gene from Brevibacterium sp. R312 by genetic complementation. Overexpression in Brevibacterium sp. and Escherichia coli | |
KR102134375B1 (en) | Microorganism for L-Lysine Production with Enhanced Cytochrome C Activity and Method of L-Lysine Production Using the Same | |
EP0759474B1 (en) | A regulatory factor involved in expression of nitrilase gene, and its gene | |
Voss et al. | Sequence of the tuf A gene encoding elongation factor EF‐Tu from Thermus aquaticus and overproduction of the protein in Escherichia coli | |
Nguyen et al. | Catabolic Ornithine Carbamoyltransferase of Pseudomonas aeruginosa: Importance of the N‐Terminal Region for Dodecameric Structure and Homotropic Carbamoylphosphate Cooperativity | |
Kanazawa et al. | Insertions of transposable elements in the promoter proximal region of the gene cluster for Escherichia coli H+-ATPase: 8 base pair repeat generated by insertion of IS 1 | |
JPH10248578A (en) | Expression vector for bacterium of genus rhodococcus | |
KR20210080975A (en) | Microorganism for L-Lysine Production with Enhanced Cytochrome C Activity and Method of L-Lysine Production Using the Same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): CH DE FR GB LI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KATO, MAMI Inventor name: YU, FUJI |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): CH DE FR GB LI |
|
17P | Request for examination filed |
Effective date: 19980318 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MITSUBISHI RAYON CO., LTD. |
|
17Q | First examination report despatched |
Effective date: 20010816 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH DE FR GB LI |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
REF | Corresponds to: |
Ref document number: 69532024 Country of ref document: DE Date of ref document: 20031204 Kind code of ref document: P |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20040730 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20140730 Year of fee payment: 20 Ref country code: CH Payment date: 20140812 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20140808 Year of fee payment: 20 Ref country code: GB Payment date: 20140730 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69532024 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20150803 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150803 |